According to another study, immunosensors use DNA and RNA as biorecognition elements by simultaneously detecting two tumor markers, carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) [137]. The gene discussed is CEACAM5; the disease is neoplasm.